Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+T cells and autoimmune vitiligo

Autoimmunity

Volumn 44, Issue 8, 2011, Pages 599-606

  Zloza, Andrew ^a   Lyons, Gretchen E ^a   Chlewicki, Lukasz K ^a   Kohlhapp, Frederick J ^a   O'Sullivan, Jeremy A ^a   Lacek, Andrew T ^a   Moore, Tamson V ^a   Jagoda, Michael C ^a   Kumar, Vinay ^a   Guevara Patio, José A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

2B4; Autoimmunity; NK receptor; NKG2D; Vitiligo

Indexed keywords

CD48 ANTIGEN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR 2B4; NATURAL KILLER CELL RECEPTOR NKG2D; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; VITILIGO;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTANT PROTEINS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; OXIDOREDUCTASES; RECEPTORS, IMMUNOLOGIC; VITILIGO;

EID: 80155192447     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.593599     Document Type: Article

References (39)

1. Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, Le Poole IC. A symbiotic concept of autoimmunity and tumour immunity: Lessons from vitiligo. Trends Immunol 2001;22(3):130-136. (Pubitemid 32675259)
2. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148(4):1219-1228. (Pubitemid 26108257)
3. + T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003;83(5):683-695. (Pubitemid 36618047)
4. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 1999;11(2):173-181. (Pubitemid 29428810)
5. Nikolic-Zugic J, Bevan MJ. Role of self-peptides in positively selecting the T-cell repertoire. Nature 1990;344(6261):65-67.
6. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997;276(5321): 2057-2062. (Pubitemid 27443614)
7. Dyall R, Bowne WB, Weber LW, LeMaoult J, Szabo P, Moroi Y, Piskun G, Lewis JJ, Houghton AN, Nikolic-Zugic J. Heteroclitic immunization induces tumor immunity. J Exp Med 1998;188(9):1553-1561. (Pubitemid 28516100)
8. EngelhornME, Guevara-Patino JA, Noffz G, Hooper AT, Lou O, Gold JS, Kappel BJ, Houghton AN. Autoimmunity and tumor immunity induced by immune responses to mutations in self. Nat Med 2006;12(2):198-206. (Pubitemid 43214746)
9. Guevara-Patino JA, Engelhorn ME, Turk MJ, Liu C, Duan F, Rizzuto G, Cohen AD, Merghoub T, Wolchok JD, Houghton AN. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest 2006;116(5): 1382-1390.
10. Engelhorn ME, Guevara-Patino JA, Merghoub T, Liu C, Ferrone CR, Rizzuto GA, Cymerman DH, Posnett DN, Houghton AN, Wolchok JD. Mechanisms of immunization against cancer using chimeric antigens.Mol Ther 2008;16(4): 773-781. (Pubitemid 351426180)
11. Duan F, Lin Y, Liu C, Engelhorn ME, Cohen AD, Curran M, Sakaguchi S, Merghoub T, Terzulli S, Wolchok JD, et al. Immune rejection of mouse tumors expressing mutated self. Cancer Res 2009;69(8):3545-3553.
12. Moretta L, Bottino C, Cantoni C, Mingari MC, Moretta A. Human natural killer cell function and receptors. Curr Opin Pharmacol 2001;1(4):387-391. (Pubitemid 33585988)
13. Biassoni R, Cantoni C, Marras D, Giron-Michel J, Falco M, Moretta L, Dimasi N. Human natural killer cell receptors: insights into their molecular function and structure. J Cell Mol Med 2003;7(4):376-387. (Pubitemid 44151688)
14. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000;12(6):721-727.
15. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002;17(1):19-29. (Pubitemid 34874615)
16. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991;173(4):1017-1020.
17. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1(2):119-126.
18. Bauer S, Groh V,Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285(5428): 727-729.
19. Schwartz RH. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71(7):1065-1068. (Pubitemid 23016541)
20. Lee KM, Bhawan S, Majima T, Wei H, Nishimura MI, Yagita H, Kumar V. Cutting edge: The NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J Immunol 2003;170(10): 4881-4885. (Pubitemid 36554715)
21. Klem J, Verrett PC, Kumar V, Schatzle JD. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: Properties required for 2B4 lytic function. J Immunol 2002;169(1):55-62. (Pubitemid 34686119)
22. Lee KM, McNerney ME, Stepp SE, Mathew PA, Schatzle JD, BennettM,KumarV.2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J ExpMed 2004;199(9):1245- 1254. (Pubitemid 38620261)
23. Kumaresan PR, Stepp SE, Verrett PC, Chuang SS, Boles KS, Lai WC, Ryan JC, Bennett M, Kumar V, Mathew PA. Molecular characterization of the rat NK cell receptor 2B4. Mol Immunol 2000;37(12-13):735-744.
24. + T cells expressing NK cell receptors in influenza A virus-infected mice. J Immunol 2000;165(9):4964-4969.
25. Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG. Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. J Immunol 2001;167(12): 6706-6710. (Pubitemid 33144158)
26. Wu Z, Kim HP, Xue HH, Liu H, Zhao K, Leonard WJ. Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity. Mol Cell Biol 2005;25(22):9741-9752. (Pubitemid 41572725)
27. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 1997;158(11):5083-5086. (Pubitemid 127681207)
28. McNerney ME, Lee KM, Kumar V. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8 + T cells. Mol Immunol 2005;42(4): 489-494. (Pubitemid 39655959)
29. Chlewicki LK, Velikovsky CA, Balakrishnan V, Mariuzza RA, Kumar V. Molecular basis of the dual functions of 2B4 (CD244). J Immunol 2008;180(12):8159-8167.
30. Houghton CS, Engelhorn ME, Liu C, Song D, Gregor P, Livingston PO, Orlandi F, Wolchok JD, McCracken J, Houghton AN, et al. Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes. Vaccine 2007;25(29):5330-5342. (Pubitemid 46977537)
31. Westerhof W, dIschia M. Vitiligo puzzle: The pieces fall in place. Pigment Cell Res 2007;20(5):345-359. (Pubitemid 47390114)
32. Guevara-Patino JA, Turk MJ, Wolchok JD, Houghton AN. Immunity to cancer through immune recognition of altered self: Studies with melanoma. Adv Cancer Res 2003;90: 157-177. (Pubitemid 37549224)
33. Houghton AN, Guevara-Patino JA. Immune recognition of self in immunity against cancer. J Clin Invest 2004;114(4): 468-471. (Pubitemid 39572095)
34. Han R, BadenHP, Brissette JL,Weiner L. Redefining the skins pigmentary system with a novel tyrosinase assay. Pigment Cell Res 2002;15(4):290-297. (Pubitemid 34829534)
35. Van Belle TL, von Herrath MG. The role of the activating receptor NKG2D in autoimmunity. Mol Immunol 2009; 47(1):8-11.
36. Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 2008;9(2):146-154.
37. Speiser DE, Colonna M, Ayyoub M, Cella M, Pittet MJ, Batard P, Valmori D, Guillaume P, Lienard D, Cerottini JC, et al. The activatory receptor 2B4 is expressed in vivo by human CD8 + effector alpha beta T cells. J Immunol 2001; 167(11):6165-6170. (Pubitemid 33081543)
38. Latchman Y, McKay PF, Reiser H. Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol 1998; 161(11):5809-5812. (Pubitemid 28535943)
39. Gonzalez-Cabrero J, Wise CJ, Latchman Y, Freeman GJ, Sharpe AH, Reiser H. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci USA 1999;96(3):1019-1023. (Pubitemid 29072176)